Table 2. Clinical characteristics related to disease severity with respect to the rs4819554 genotype distribution.
Cohort 1 (n = 180) | Cohort 2 (n = 419) | Both cohorts (n = 599) | |||||||
---|---|---|---|---|---|---|---|---|---|
AA genotype n = 104 | Gx genotype n = 76 | p | AA genotype n = 240 | Gx genotype n = 179 | p | AA genotype n = 344 | Gx genotype n = 255 | p | |
BASDAI, mean (SD) | 3 (2.2) | 3.3 (2.2) | NS | 3.9 (2.5) | 4.4 (2.3) | <0.05 | 3.7 (2.7) | 4.1 (2.6) | <0.05 |
BASDAI adjusted by duration of disease evolution, mean (SD) | 0.19 (0.29) | 0.23 (0.35) | NS | 0.18 (0.12) | 0.22 (0.13) | <0.05 | 0.19 (0.24) | 0.22 (0.29) | NS |
BASFI, mean (SD) | 3.1 (2.6) | 4.2 (2.7) | <0.01 | 3.7 (2.7) | 4.3 (2.8) | <0.05 | 3.7 (2.7) | 4.2 (2.8) | <0.05 |
BASFI adjusted by duration of disease evolution, mean (SD) | 0.15 (0.13) | 0.21 (0.14) | <0.01 | 0.15 (0.12) | 0.19 (0.13) | <0.01 | 0.15 (1.4) | 0.19 (1.4) | <0.01 |
Note: Gx genotype includes GG and GA genotypes